19
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 21121.
Regulatory Information RX
With a dosage strength 27MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2002-04-01
Therapeutic Equivalence (TE) Code AB
18
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 21121.
Regulatory Information RX
With a dosage strength 36MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2000-08-01
Therapeutic Equivalence (TE) Code AB
17
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 21121.
Regulatory Information RX
With a dosage strength 54MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2000-12-08
Therapeutic Equivalence (TE) Code AB
16
Johnson & Johnson Innovative Medicine, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is METHYLPHENIDATE HYDROCHLORIDE, with a corresponding application number 21121.
Regulatory Information RX
With a dosage strength 18MG
Dosage Form Route TABLET, EXTENDED RELEASE; ORAL
Reference Listed Drug Yes
Approved since 2000-08-01
Therapeutic Equivalence (TE) Code AB